BMY

BMY

BMY

Letters With This Ticker

Quarter Letter Date Fund Name QTD YTD Tickers Keywords/Themes Theme Commentary Pitches Letter
2025 Q4 Jan 18, 2026 Distillate Capital Fundamental Stability & Value 0.0% 0.0% BMY, CAH, CSCO, ELV, FFIV, FI, GPS, HCA, JBHT, JNJ, LOW, MO, MPC, MRK, REGN, TDC, TEL, TMUS, UBER, VST free cash flow, fundamentals, international, Quality, rebalancing, small caps, valuation, value
2025 Q4 Jan 18, 2026 Distillate Capital Small/Mid Cap Quality & Value 0.0% 0.0% BMY, CAH, CSCO, ELV, FFIV, FI, GPS, HCA, JBHT, JNJ, LOW, MO, MPC, MRK, REGN, TDC, TEL, TMUS, UBER, VST free cash flow, fundamentals, Quality, rebalancing, small cap, valuation, value
2025 Q4 Jan 18, 2026 Distillate Capital Large Cap Value 0.0% 8.6% 000660.KS, 005930.KS, BMY, CAH, CSCO, ELV, FFIV, FI, HCA, JBHT, JNJ, LOW, MO, MPC, MRK, REGN, TEL, TMUS, UBER, VST FCF, fundamentals, international, Quality, rebalancing, small caps, valuation, value
2025 Q4 Jan 18, 2026 Ariel Global Fund 2.9% 23.3% 000660.KS, 1024.HK, 4751.T, 6367.T, 6460.T, 6762.T, 6856.T, 7832.T, BIRG.L, BMPS.MI, BMY, FME.DE, FORTUM.HE, FSLR, HPE, LREN3.SA, SAN, T, WBS, WCH.DE AI, Banking, Data centers, Energy Transition, global, international, semiconductors, value ES
WBS
WCH GR
1024 HK
6367 JP
4751 JP
BMY
T
000660 KS
6920 JP
FSLR
2023 Q4 Feb 26, 2024 Aristotle Core Equity Fund 2.9% 21.3% 0YXG LN, BDX, BMY, HAL, LLY, PEP, SPR, VRTX -
2023 Q4 Feb 26, 2024 Aristotle Atlantic Core Equity Strategy 3.1% 21.7% 0YXG LN, BDX, BMY, HAL, LLY, PEP, SPR, VRTX -
2023 Q4 Jan 31, 2024 Ariel Global Fund 6.9% 0.0% BIDU, BMY, CNH, DSN0 GR, FUH0 GR, INTC, KB, O2D GR, TFC, VZ, WIZZ LN -

Pitches With This Ticker

Date Pitch Type Author Company Industry Sub Industry Bull / Bear Stock Exchange Keywords Action
Jan 25, 2026 Seeking Alpha Seeking Alpha Bristol-Myers Squibb Company Pharmaceuticals Biopharmaceuticals Neutral New York Stock Exchange biopharmaceuticals, Bristol-Myers Squibb, CAR-T expansion, CELMoDs, Dividend coverage, Eliquis patent cliff, execution risks, growth portfolio, legacy erosion, Valuation reset
Jan 20, 2026 Fund Letters Rupal J. Bhansali Bristol-Myers Squibb Company Health Care Pharmaceuticals Bull New York Stock Exchange dividends, Oncology, pharma, pipeline, valuation
Nov 4, 2025 Seeking Alpha Seeking Alpha Bristol-Myers Squibb Company Drug Manufacturers - General Bull Breyanzi, Bristol-Myers Squibb, Camzyos, CAR T-cell therapy, growth portfolio, Hematology, innovation, Orbital Therapeutics, pharmaceuticals, Reblozyl
Aug 13, 2025 Seeking Alpha Gen Alpha Bristol Myers Squibb Health Care Drug Manufacturers - General Bull NYSE
Aug 8, 2025 Seeking Alpha Endurance Investing Bristol Myers Squibb Health Care Drug Manufacturers - General Bull NYSE

BSD Shareholders of BMY

This report provides a detailed summary of investor holdings for a specified stock ticker, highlighting key metrics such as fund name, total assets under management (AUM), invested value, portfolio weight, and shares owned. It also tracks changes in share ownership during the last quarter, including the percentage of shares bought or sold and the percentage of outstanding shares owned. The data is generated using an API that processes investor holdings and calculates these values for each fund. This report helps investors and analysts monitor the stock positions of major funds, identify investment trends, and assess the influence of large investors on individual stocks.

Filing Date: September 30, 2025
Manager Name Fund Name Fund AUM Invested Value Portfolio Weight Shares Owned Shares Bought / Sold During Quarter % Bought / Sold During Quarter % of Shares Outstanding Owned
No investor data available.